14.01.2014

Elanix - Investment Opportunity in Regenerative and Reconstructive medicine

Elanix - a young start-up focused on regenerative medicine, contracted/outsourced certain management and preparatory activities to Tagator.

One of them is search of funding. Seed capital has been secured early in 2012 and now Elanix is soliciting  CHF 5-10m of round A for industrialisation and regulatory process.

Brief company memorandum provides more information

Images